Trials / Completed
CompletedNCT05858294
The Safety, Acceptability and Efficacy of Alena
The Safety, Acceptability and Efficacy of Alena, a Modularized CBT-based Mobile App Intervention for Social Anxiety: a Randomised Controlled Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 102 (actual)
- Sponsor
- Aya Technologies Limited · Industry
- Sex
- Female
- Age
- 18 Years – 35 Years
- Healthy volunteers
- Accepted
Summary
The present study is a randomised controlled trial that seeks to investigate the safety, acceptability and efficacy and safety of the Alena CBT programme as a treatment for social anxiety disorder.
Detailed description
This is a 6-week web-based parallel-group unblinded randomised controlled trial with a 4-week intervention period and a 2-week follow-up post intervention. Participants are randomly allocated to receive access to the Alena CBT programme or to a wait list control group, in a 1:1 ratio. The programme consists of CBT-based therapy for social anxiety based on the Clark and Wells model.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Cognitive Behavioral Therapy programme | This mobile application comprised CBT-based therapy for social anxiety based on the Clark and Wells model |
Timeline
- Start date
- 2022-10-31
- Primary completion
- 2022-12-04
- Completion
- 2022-12-18
- First posted
- 2023-05-15
- Last updated
- 2023-05-15
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT05858294. Inclusion in this directory is not an endorsement.